XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)
$8.16 -0.18 (-2.1583%)
Analysed XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) News Sources
Xeris Biopharma Q1 Earnings Call Highlights
09-05-2026
marketbeat.com
Results: Xeris Biopharma Holdings, Inc. Confounded Analyst Expectations With A Surprise Profit
09-05-2026
yahoo.com
Shareholders Will Be Pleased With The Quality of Xeris Biopharma Holdings' (NASDAQ:XERS) Earnings
15-05-2026
yahoo.com
Xeris Biopharma Announces Private Exchange of Convertible Notes
11-06-2026
yahoo.com
Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS®
11-06-2026
yahoo.com
Jim Cramer Blesses a Caller’s Speculative Investment in Xeris Biopharma
12-06-2026
yahoo.com
Xeris Announces Updates to Its Board of Directors
30-06-2026
yahoo.com
Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity?
30-06-2026
yahoo.com
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
03-07-2026
yahoo.com
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last?
08-07-2026
yahoo.com
What is the current price of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)?
The current price of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) is $8.16.
XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) absolute price change since previous trading day?
The absolute price change of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) since the previous trading day is $-0.18.
XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) percentage price change since previous trading day?
The percentage price change of XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) since the previous trading day is -2.1583%.
What is the most recent average sentiment score for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)?
The most recent average sentiment score for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)?
The most recent sentiment for XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ) is .
SEC-8K** Filing Available For XERIS BIOPHARMA HOLDINGS INC (XERS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.